| Net Cash Provided by (Used in) Operating Activities |
$976,000 |
USD |
-162% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,004,000 |
USD |
177% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
-98% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11,246,252 |
shares |
23% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$47,000 |
USD |
683% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,598,000 |
USD |
77% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$1,598,000 |
USD |
77% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$48,000 |
USD |
94% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$5,170,000 |
USD |
185% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$1,000 |
USD |
-67% |
Q1 2024 |
Q1 2024 |
| Interest Expense |
$65,000 |
USD |
62% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |